| Literature DB >> 28626260 |
Akashi Fujita1, Masahiro Tajika2, Tsutomu Tanaka2, Makoto Ishihara2, Yutaka Hirayama2, Nobumasa Mizuno1, Kazuo Hara1, Susumu Hijioka1, Hiroshi Imaoka1, Tsukasa Yoshida1, Nozomi Okuno1, Nobuhiro Hieda1, Takashi Hirayama1, Hitoshi Shibuya1, Hisashi Kondo1, Hirotaka Suzuki1, Kazuhiro Toriyama1, Yasushi Yatabe3, Kenji Yamao1, Yasumasa Niwa2.
Abstract
API2-MALT1 translocation-positive gastric marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT) lymphoma is thought to transform to diffuse large B-cell lymphoma (DLBCL) rarely. A 69-year-old man presented with epigastralgia. Esophagogastroduodenoscopy showed multiple ulcerations in the stomach. Endoscopic biopsies revealed MALT lymphoma, with Helicobacter pylori infection. The patient underwent eradication therapy with no improvement, and was thereafter followed without additional therapy at his request. Twelve years after initial diagnosis, follow-up computed tomography (CT) showed multiple nodules in bilateral lungs, and a needle biopsy revealed MALT lymphoma, the same as in the stomach and API2-MALT1 translocation was found. Because he again refused additional therapy, follow-up was continued. 15 years after initial diagnosis, CT showed lymphadenopathy at the splenic hilum. At first we suspected disease progression of gastric MALT lymphoma, however a needle biopsy revealed DLBCL without API2-MALT1. Thus, the tumor at the splenic hilum was finally diagnosed as a de novo DLBCL as a second malignancy. Although treatment with rituximab given his age and his wishes was attempted, he died of DLBCL 15 years after the initial diagnosis. We experienced an API2-MALT1-positive gastric MALT lymphoma with concomitant DLBCL, not transformed to DLBCL over a 15-year clinical course.Entities:
Keywords: API2-MALT1; DLBCL; MALT lymphoma; Second malignancy
Mesh:
Substances:
Year: 2017 PMID: 28626260 PMCID: PMC5472550 DOI: 10.18999/nagjms.79.2.251
Source DB: PubMed Journal: Nagoya J Med Sci ISSN: 0027-7622 Impact factor: 1.131